← Back

Wire · opportunities

Human factors isn't a checkbox: What FDA's eSTAR requirements mean for MedTech submissions

Published

14 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at medtechdive.com

Verified

Fusion42 · 14 September 2026 · Fusion42 review

The FDA's new 2026 eSTAR v7.0 guidance for medical device submissions shifts the focus from simply validating human factors to demonstrating that use-related risks are acceptably managed. Device risk category now defines the level of human factors evidence needed, with Category 3 devices requiring human factors validation tests due to critical tasks that could cause severe harm.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

Medical device founders must redesign submission strategies around risk-based human factors evidence, not just usability tests. Prepare to produce detailed risk analyses and documentation earlier, or face delayed market access under FDA's new demands.

Coverage

1 source · 14 Sep 2026

Related on Wire

Topics

Medtechhuman-factorsFDAmedtech-submissionsrisk-classificationeSTARregulatory-compliance